NeoProteomics AB moves to Uppsala

This August, we see a new and exciting addition to Uppsala`s life science business sector. Based on research by Professor Gert Auer at Karolinska Institute, NeoProteomics AB started the development of biomarkers for sensitive and risk-free cancer diagnosis by analyzing platelets role in cancer. Blood-based liquid biopsy products for cancer diagnosis are extremely patient friendly and safecompared to current tissue biopsies, and a growing market. Company focus is now to develop the first in a series of products based on proprietary platelet biomarkers. The first diagnostic product for early detection of colorectal cancer will be ready for testing next year.

Uppsala offers a great environment for life science-based companies. We believe that Uppsala is a good location when you plan to develop a new life science company with growth potential and we are pleased to start our activities based in Uppsala Business Park this autumn says Torbjörn Pettersson, CEO of the company.